PIPELINE

PIPELINE

OGB21501 is a long-acting tetra-agonist medicine that uses the Onegene Biotechnology's protein conjugation platform for treating obesity and nonalcoholic steatohepatitis (drug). Four different APIs were designed to have synergistic or supplementary effects on the brain, adipose tissue, liver, and pancreas, respectively, which play a major role in obesity and NASH, to reduce food intake, increase energy expenditure, promote insulin secretion, reduce insulin resistance, and have lipolysis, anti-inflammation, and anti-fibrotic effects, while combining with albumin to improve its half-life in the body.

COPYRIGHT INFORMATION GOES ‌ONEGENE BIOTECHNOLOGY © 2016. ALL RIGHTS RESERVED